68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity.
Jothilingam SivapackiamShivesh KabraSylvia SpeidelMonica SharmaRichard LaforestAmber SalterMichael P RettigVijay SharmaPublished in: PloS one (2019)
68Ga-Galmydar could provide a noninvasive assessment of DOX-related and likely reversible metabolic changes at earliest stages. Further studies with other chemotherapeutics (potentially capable of inducing cardiomyopathy) are underway.